Tukysa (tucatinib) Treatment Experience

rethink_breast_cancer

My name of MJ DeCoteau and I am the executive director of Rethink Breast Cancer (www.rethinkbreastcancer.com) – a Canadian patient group dedicated to building community for young women dealing with breast cancer and providing support and resources to help them live the best quality of life.

The Canadian government will soon be reviewing the use of Tukysa (tucatinib) to treat HER2-positive metastatic breast cancer and Rethink Breast Cancer will be making a submission to ensure that patient voices are represented and considered during the review process.

Does this survey apply to you?

We are looking for patients with HER2-positive locally advanced unresectable or metastatic breast cancer and patients who have been treated with Tukysa to talk about their treatment experience.

YOU DO NOT NEED TO LIVE IN CANADA TO PARTICIPATE.

If you are interested in talking about your experiences, we would like to ask you to complete this survey: https://www.surveymonkey.com/r/Tukysa

If you would like to speak with us directly about your cancer or treatment experience, you can contact me at MJ@rethinkbreastcancer.com.

MJ DeCoteau

Founder + Executive Director

Rethink Breast Cancer

illimae

Done. Completed by patient and caregiver.

rethink_breast_cancer

Thank you

rethink_breast_cancer

bump

Kitkat703

also completed the survey.

BUMP